{"id":"https://genegraph.clinicalgenome.org/r/5d2e837d-de2f-4f4c-ba38-76f191effecav1.0","type":"EvidenceStrengthAssertion","dc:description":"Homozygous variants in CDK5RAP2 were first reported individuals with microcephaly in consanguineous family in 2005 (Bond J, et al., PMID: 15793586). Primary microcephaly (OMIM:604804) characterized by a disproportionately small brain and cerebral cortex further characterized by other significant neurological deficits (delayed psychomotor development, moderate learning difficulties, and significant speech delay). Other clinical manifestation as variation were reported: severe sensorineural hearing loss (Pagnamenta et al. (2012), short stature (-6.7 SD), prominent eyes, conical-shaped and widely spaced teeth (Lancaster et al. (2013)). The mechanism of pathogenicity is known to be autosomal recessive loss-of-function. At least nine loss-of-function variants, 3 homozygous and 6 compound heterozygous, have been reported in 6 probands with primary microcephaly, 3 across six publications (PMIDs: 17764569, 15793586, 22887808, 27761245, 23726037, 23995685). This gene-disease relationship is also supported by patient-derived cerebral organoid (PMID: 23995685) and phenotypically compatible mouse model (PMIDs: 20460369). Inducing wildtype CDK5RAP2 expression rescued the developmental abnormality in patient-derived cerebral organoid, which is genetically knock-out for CDK5RAP2 (PMID: 23995685). In summary, CDK5RAP2 is definitively associated with autosomal recessive primary microcephaly, 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This was discussed and approved by the ClinGen Brain Malformations Gene Curation Expert Panel on 01/25/2022 (SOP Version 8).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5d2e837d-de2f-4f4c-ba38-76f191effeca","GCISnapshot":"https://genegraph.clinicalgenome.org/r/70dace84-4d61-44f5-9de5-a81b5c70cad4","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/70dace84-4d61-44f5-9de5-a81b5c70cad4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2022-01-25T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/70dace84-4d61-44f5-9de5-a81b5c70cad4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2022-04-11T12:47:37.371Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70dace84-4d61-44f5-9de5-a81b5c70cad4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70dace84-4d61-44f5-9de5-a81b5c70cad4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03e0d4ea-5019-4886-ae99-77b6f523c6b5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bfd75fb-7e9b-432b-8f5a-05da2dbe0a68","type":"Finding","dc:description":"The mutant mice showed microcephaly with hypoplasia of several brain regions, including the cortex and hippocampus. Neuronal progenitors from the mutant mice showed proliferative and survival defects: they exited the cell cycle prematurely and many underwent apoptosis. These defects were associated with impaired mitotic progression coupled with abnormal mitotic spindle pole number and mitotic orientation. These findings suggested that the reduction in brain size observed in humans with mutations in CDK5RAP2 is associated with impaired centrosomal function and with changes in mitotic spindle orientation during the proliferation of neuronal progenitors. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20460369","rdfs:label":"Mouse model by non-functional Cdk5rap2","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a71516df-a1a1-4124-b4df-37d5fa7f9b7f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5274d9ea-ff76-4fe8-b9c4-5f292ad540f5","type":"Finding","dc:description":"Control tissues displayed abundant, large neuroepithelial tissues composed of progenitors, patient-derived tissues displayed only occasional neuroepithelial regions (Extended Data Fig. 7e). Furthermore, these tissues displayed decreased RGs and increased neurons compared with control (Fig. 6f and Extended Data Fig. 7f), suggesting premature neural differentiation. To test this possibility, we performed BrdU pulse-chase experiments (Fig. 6g), which revealed a marked increase in the number of BrdU+/doublecortin (DCX)+cells in patient organoids, consistent with premature neurogenic non-proliferative divisions.\n\nAs a further independent approach, we performed RNAi knockdown of CDK5RAP2 by co-electroporating GFP with two independent shRNAs found to knock down endogenous CDK5RAP2 (Extended Data Fig. 8a). Both shRNAs led to a considerable loss of SOX2+ progenitors and an increase in DCX+ neurons (Fig. 6i and Extended Data Fig. 8b), reflecting a statistically significant increase in neuron production rather than progenitor maintenance (Extended Data Fig. 8c). These findings support the conclusion that loss of CDK5RAP2 leads to premature neural differentiation at the expense of progenitors.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23995685","rdfs:label":"A cerebral organoid culture of loss-of-function in CDK5RAP2","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a7360832-6807-412c-85da-cceccedc6d22","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34ef5d31-8cd8-45b3-9eae-57a961269329","type":"Finding","dc:description":"The extent of neuroepithelial differentiation and the number of radial glia, which were decreased in the patient's brain organoid, were increased after electroporation of wildtype CDK5RAP2. This differentiation and cellular developmental process are characterized in wild-type brain development.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23995685","rdfs:label":"Electroporation of CDK5RAP2 in knockout brain organoid","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/70dace84-4d61-44f5-9de5-a81b5c70cad4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85df8f7f-ec6a-4edd-b664-09296e606bff_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4849fdc-871c-419a-9c0f-f8731f1a51f3","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4849fdc-871c-419a-9c0f-f8731f1a51f3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"dd","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/b4849fdc-871c-419a-9c0f-f8731f1a51f3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22887808","allele":{"id":"https://genegraph.clinicalgenome.org/r/24ceaef4-fa1b-4ea0-9e2d-975aabda2638","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.700G>T (p.Glu234Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA266224"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/85df8f7f-ec6a-4edd-b664-09296e606bff","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22887808","rdfs:label":"Somali","allele":{"id":"https://genegraph.clinicalgenome.org/r/24ceaef4-fa1b-4ea0-9e2d-975aabda2638"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b4849fdc-871c-419a-9c0f-f8731f1a51f3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7f2b6b28-c194-4f98-a31d-e8eedefb1e84_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6f82c41-a7ea-4f7b-88a1-19c610f5cb6c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6f82c41-a7ea-4f7b-88a1-19c610f5cb6c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27761245","allele":{"id":"https://genegraph.clinicalgenome.org/r/508087d6-50b3-4327-963d-3a1c3f722e51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.4604+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351602"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d6917ba3-e3d1-494b-bdb9-bdd061f6129c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6917ba3-e3d1-494b-bdb9-bdd061f6129c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27761245","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1f464c8-1e75-4f53-9833-f0e6abeab67d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.3097del (p.Val1033fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA059812"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7f2b6b28-c194-4f98-a31d-e8eedefb1e84","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27761245","rdfs:label":"BRC081","allele":[{"id":"https://genegraph.clinicalgenome.org/r/f1f464c8-1e75-4f53-9833-f0e6abeab67d"},{"id":"https://genegraph.clinicalgenome.org/r/508087d6-50b3-4327-963d-3a1c3f722e51"}],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d6917ba3-e3d1-494b-bdb9-bdd061f6129c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e6f82c41-a7ea-4f7b-88a1-19c610f5cb6c_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/17962f3a-0968-4205-89f5-c94b48ef2205_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac172c2b-594c-4c3d-8ec3-39a026294fed","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac172c2b-594c-4c3d-8ec3-39a026294fed_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Using a minigene splicing vector assay, we determined that IVS26–15A → G creates a new, superior splice acceptor site, leading to the addition of four new amino acids and a termination codon (E385fsX4; Supplementary Figs. 5 and 6 online).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ac172c2b-594c-4c3d-8ec3-39a026294fed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15793586","allele":{"id":"https://genegraph.clinicalgenome.org/r/b18e6319-2b6b-458a-b857-4a327f775002","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.4005-15A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339994"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/17962f3a-0968-4205-89f5-c94b48ef2205","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15793586","rdfs:label":"Pedigree 2_1","allele":{"id":"https://genegraph.clinicalgenome.org/r/b18e6319-2b6b-458a-b857-4a327f775002"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ac172c2b-594c-4c3d-8ec3-39a026294fed_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/8428c35e-b2a1-4861-87f7-3f801ef64ac4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57218cfe-a910-4f0b-8e36-a8ddf93c7933","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57218cfe-a910-4f0b-8e36-a8ddf93c7933_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17764569","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a20d0a7-4ab0-41d6-b1d2-5910e040b5c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.246T>A (p.Tyr82Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342318"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8428c35e-b2a1-4861-87f7-3f801ef64ac4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17764569","rdfs:label":"V-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a20d0a7-4ab0-41d6-b1d2-5910e040b5c3"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/57218cfe-a910-4f0b-8e36-a8ddf93c7933_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/70dace84-4d61-44f5-9de5-a81b5c70cad4_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6c5114d-23df-41cb-9258-72f0ba04894e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27761245","rdfs:label":"Pagnamenta et al BRC081","family":{"id":"https://genegraph.clinicalgenome.org/r/b6c5114d-23df-41cb-9258-72f0ba04894e","type":"Family","rdfs:label":"Pagnamenta et al BRC081","member":{"id":"https://genegraph.clinicalgenome.org/r/7f2b6b28-c194-4f98-a31d-e8eedefb1e84"}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/7f2b6b28-c194-4f98-a31d-e8eedefb1e84"}},{"id":"https://genegraph.clinicalgenome.org/r/0d9f4506-0cdb-42f5-a040-d3fc954d6b33_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22887808","rdfs:label":"Pagnamenta et al Somali","family":{"id":"https://genegraph.clinicalgenome.org/r/0d9f4506-0cdb-42f5-a040-d3fc954d6b33","type":"Family","rdfs:label":"Pagnamenta et al Somali","member":{"id":"https://genegraph.clinicalgenome.org/r/85df8f7f-ec6a-4edd-b664-09296e606bff"}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/85df8f7f-ec6a-4edd-b664-09296e606bff"}},{"id":"https://genegraph.clinicalgenome.org/r/3c53a4cd-ece2-4c3f-a22b-8901d7fe15bb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23995685","rdfs:label":"Lancaster et al A3842","family":{"id":"https://genegraph.clinicalgenome.org/r/3c53a4cd-ece2-4c3f-a22b-8901d7fe15bb","type":"Family","rdfs:label":"Lancaster et al A3842","member":{"id":"https://genegraph.clinicalgenome.org/r/4c202a18-933d-4a46-935d-4d4df4b6fe8f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23995685","rdfs:label":"A3842","allele":[{"id":"https://genegraph.clinicalgenome.org/r/98497795-4f19-4545-b246-844ddc347fa9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.4546G>T (p.Glu1516Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA266227"}},{"id":"https://genegraph.clinicalgenome.org/r/197b5f9c-a1cf-4be3-acaa-ce7c1877c808","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.4672C>T (p.Arg1558Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA266230"}}],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4c35d26b-9c8d-4559-87da-63b664a81372_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23995685","allele":{"id":"https://genegraph.clinicalgenome.org/r/98497795-4f19-4545-b246-844ddc347fa9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/bd073031-edda-4958-815a-4d4b0e664cf5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23995685","allele":{"id":"https://genegraph.clinicalgenome.org/r/197b5f9c-a1cf-4be3-acaa-ce7c1877c808"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/4c202a18-933d-4a46-935d-4d4df4b6fe8f"}},{"id":"https://genegraph.clinicalgenome.org/r/689416a3-2ce4-44b4-b8bb-14ca1fd8cbdb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17764569","rdfs:label":"Hassan et al Family A","estimatedLodScore":1.93,"family":{"id":"https://genegraph.clinicalgenome.org/r/689416a3-2ce4-44b4-b8bb-14ca1fd8cbdb","type":"Family","rdfs:label":"Hassan et al Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/8428c35e-b2a1-4861-87f7-3f801ef64ac4"}},"phenotypeFreeText":"microcephaly was present by birth in all affected individuals. Head circumferences of affected individuals were 4–7 standard deviations below the age- and sex-related means. Affected individuals examined were 18 to 30 years old and mental retardation ranged from mild to moderate in severity. The facial features of the affected individuals are normal except an indistinct slopping forehead (Figure ​(Figure2).2). With the exception of intellectual impairment, no other neurological problems were observed in the affected individuals.","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8428c35e-b2a1-4861-87f7-3f801ef64ac4"}},{"id":"https://genegraph.clinicalgenome.org/r/34647097-b6da-4a6f-b49b-a37969d471c8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23726037","rdfs:label":"Tan et al","family":{"id":"https://genegraph.clinicalgenome.org/r/34647097-b6da-4a6f-b49b-a37969d471c8","type":"Family","rdfs:label":"Tan et al","member":{"id":"https://genegraph.clinicalgenome.org/r/818b0605-b628-4d7b-ba5e-d7d918326a8e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23726037","rdfs:label":"Tan et al proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/3f8965aa-8f8d-48d8-a260-1aca7d301086","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.4005-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA271213"}},{"id":"https://genegraph.clinicalgenome.org/r/e9f7c52c-cbfb-46bc-beef-9cac6b0cadeb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018249.6(CDK5RAP2):c.524_528del (p.Gln175fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA271232"}}],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/237d670c-47dd-485f-9338-4013eab15837_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23726037","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f8965aa-8f8d-48d8-a260-1aca7d301086"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/aeaddc8f-4093-46d4-a321-65835724181c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23726037","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9f7c52c-cbfb-46bc-beef-9cac6b0cadeb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/818b0605-b628-4d7b-ba5e-d7d918326a8e"}},{"id":"https://genegraph.clinicalgenome.org/r/afc90047-218b-4184-b796-187188b96ac8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15793586","rdfs:label":"Bond et al Pedigree 2","family":{"id":"https://genegraph.clinicalgenome.org/r/afc90047-218b-4184-b796-187188b96ac8","type":"Family","rdfs:label":"Bond et al Pedigree 2","member":{"id":"https://genegraph.clinicalgenome.org/r/17962f3a-0968-4205-89f5-c94b48ef2205"}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/17962f3a-0968-4205-89f5-c94b48ef2205"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/818b0605-b628-4d7b-ba5e-d7d918326a8e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aeaddc8f-4093-46d4-a321-65835724181c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aeaddc8f-4093-46d4-a321-65835724181c_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/237d670c-47dd-485f-9338-4013eab15837","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/237d670c-47dd-485f-9338-4013eab15837_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/818b0605-b628-4d7b-ba5e-d7d918326a8e"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/4c202a18-933d-4a46-935d-4d4df4b6fe8f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c35d26b-9c8d-4559-87da-63b664a81372","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c35d26b-9c8d-4559-87da-63b664a81372_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Skin fibroblasts from this patient revealed a loss of the CDK5RAP2 protein (Figure 6c, Extended Data Figure 6b) suggesting loss of function, consistent with previously reported CDK5RAP2 mutations in primary microcephaly patients.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4c35d26b-9c8d-4559-87da-63b664a81372_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bd073031-edda-4958-815a-4d4b0e664cf5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd073031-edda-4958-815a-4d4b0e664cf5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Skin fibroblasts from this patient revealed a loss of the CDK5RAP2 protein (Figure 6c, Extended Data Figure 6b) suggesting loss of function, consistent with previously reported CDK5RAP2 mutations in primary microcephaly patients.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bd073031-edda-4958-815a-4d4b0e664cf5_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4c202a18-933d-4a46-935d-4d4df4b6fe8f"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":4207,"specifiedBy":"GeneValidityCriteria8","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JCKoY36zSZ8","type":"GeneValidityProposition","disease":"obo:MONDO_0016660","gene":"hgnc:18672","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_70dace84-4d61-44f5-9de5-a81b5c70cad4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}